Dietary methionine imbalance, endothelial cell dysfunction and atherosclerosis

Nutrition Research

Volumn 16, Issue 7, 1996, Pages 1251-1266

  Toborek, Michal ^a   Hennig, Bernhard ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Atherosclerosis; Endothelial Cells; Homocysteine; Methionine

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHIONINE; PYRIDOXINE; RIBOFLAVIN;

AMINO ACID METABOLISM; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; DIET; ENDOTHELIUM CELL; HUMAN; LIPID ANALYSIS; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR;

ANIMALIA;

EID: 0030009984     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/0271-5317(96)00128-5     Document Type: Review

References (86)

1. Pan M, Fischer CP, Wasa M, Lukaszewicz G, Stevens BR, Bode BP, Abcouwer SF, Souba WW. Amino acid metabolism and the vascular endothelium: regulation and disease implications. Shock 1995; 4:79-88.
2. Hinshaw DB, Burger JM. Protective effect of glutamine on endothelial cell ATP in oxidant injury. J Surg Res 1990; 49:222-7.
3. Spolarics Z, Lang CH, Bagby GJ, Spitzer JJ. Glutamine and fatty acid oxidation are the main sources of energy for Kupffer and endothelial cells. Am J Physiol 1991; 261:G185-90.
4. Kuo L, Davis MJ, Cannon MS, Chilian WM. Pathophysiological consequences of atherosclerosis extend into the coronary microcirulation. Restoration of endothelium-dependent responses by L-ariginine. Circ Res 1992; 70:465-76.
5. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbits. J Clin Invest 1992; 90:1168-72.
6. Beutler E. Nutritional and metabolic aspects of glutathione. Ann Rev Nutr 1989; 9:287-302.
7. Hennig B, Toborek M, Alvarado Cader A, Decker E. Nutrition, endothelial cell metabolism, and atherosclerosis. Crit Rev Food Sci Nutr 1994; 34:253-82.
8. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801-9.
9. Toborek M, Hennig B. Is methionine an atherogenic amino acid? J Opt Nutr 1994; 3:80-3.
10. Toborek M, Kopieczna-Grzebieniak E, Drózdz M, Wieczorek M. Increased lipid peroxidation as a mechanism of methionine-induced atherosclerosis in rabbits. Atherosclerosis 1995; 115:217-24
11. Rubanyi GM. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 1993; 22:S1-14.
12. Davies MG, Hagen PO. The vascular endothelium. Ann Surg 1993; 218:593-609.
13. Nabel EG. Biology of the impaired endothelium. Am J Cardiol 1991; 68:C6-8.
14. Furchgott RF, Vanhoutte PM. Endothelium derived relaxing and contracting factors. FASEB J 1989; 3:2007-17.
15. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323:27-36.
16. Gertler JP, Abbott WM. Prothrombotic and fibrinolytic function of normal and perturbed endothelium. J Surg Res 1992; 52:89-95.
17. DiCorleto PE, Chisolm GM. Participation of the endothelium in the development of the atherosclerotic plaque. Prog Lipid Res 1986; 25:365-74.
18. DiCorleto PE. Cellular mechanisms of atherogenesis. Am J Hypertens 1993; 6:S314-18.
19. Hennig B, Diana JN, Toborek M, McClain CJ. Influence of nutrients and cytokines on endothelial cell metabolism. J Am Coll Nutr 1994; 13:224-31.
20. Resnick N, Gimbrone Jr MA. Hemodynamic forces are complex regulators of endothelial gene expression. FASEB J 1995; 9:874-82.
21. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995; 91:2488-96.
22. Offermann MK, Medford RM. Antioxidants and atherosclerosis: a molecular perspective. Heart Dis Stroke 1994; 3:52-7.
23. Hajjar DP, Nicholson AC. Atherosclerosis. Amer Sci 1995; 83:460-7.
24. Simionescu M, Simionescu N. Proatherosclerotic events: pathobiochemical changes occurring in the arterial wall before monocyte migration. FASEB J 1993; 7:1359-66.
25. Mudd SH, Levy HL. Disorders of transsulfuration. In: Wyngaarden JB, Fredericson DS, Goldstein JL, Brown MS, eds. The metabolic basis of inherited disease. McGrew-Hill, 1983; 522-59.
26. Hultberg B, Andersson A, Isaksson A. Metabolism of homocysteine, its relation to the other cellular thiols and its mechanisms of cell damage in a cell culture line (human histiocytic cell line U-937). Biochem Biophys Acta 1995; 1269:6-12.
27. Ewadh MJA, Tudball N, Rose FA. Homocysteine uptake by human umbilical vein endothelial cells in culture. Biochim Biophys Acta 1990; 1054:263-6.
28. Bannai S, Tateishi N. Role of membrane transport in metabolism and function of glutathione in mammals. J Membr Biol 1986; 89:1-8.
29. Cooper AJL. Biochemistry of sulfur containing amino acids. Ann Rev Biochem 1983; 52:187-222.
30. Finkelstein JD, Martin JJ. Methionine metabolism in mammals. Adaptation to methionine excess. J Biol Chem 1986; 261:1582-97.
31. Wang J, Dudman NP, Wilcken DE, Lynch JF. Homocysteine catabolism: levels of 3 enzymes in cultured human vascular endothelium and their relevance to vascular disease. Atherosclerosis 1992; 97:97-106.
32. Butterworth M, Upshall DG, Hobbs M, Cohen GM. Elevation of cysteine and replenishment of glutathione in rat lung slices by cysteine isopropylester and other cysteine precursors. Biochem Pharmacol 1993; 45:1769-74.
33. Kritchevsky D. Dietary protein and experimental atherosclerosis. Ann NY Acad Sci 1993; 676:180-7.
34. Muramatsu K, Sugiyama K. Relationship between amino acid composition of dietary protein and plasma cholesterol level in rats. In: Sugano M, Beynen AC, eds. Dietary proteins, cholesterol metabolism and atherosclerosis, Vol 16 Basel, Switzerland: Karger, 1990; 97-109.
35. Barth CA, Pfeuffer M. Dietary protein and atherogenesis. Klin Wochenschr 1988; 66:135-43.
36. Guder W, Nolte I, Wieland O. The influence of thyroid hormones on β-hydroxy-β-methylglutaryl coenzyme A reductase of rat liver. Eur J Biochem 1968; 4:273-8.
37. Yagasaki K, Aoki T, Funabiki R. Serum and liver responses to methionine and cystine in rats fed diets with different casein levels. Nutr Rep Int 1986; 34:59-66.
38. Sugiyama K, Akai H, Muramatsu K. Effects of methionine and related compounds on plasma cholesterol level in rats fed a high cholesterol diet. J Nutr Sci Vitaminol 1986; 32:537-49.
39. Kurowska EM, Carroll KK. Effect of high levels of selected dietary essential amino acids on hypercholesterolemia and down-regulation of LDL receptors in rabbits. Biochim Biophys Acta 1992; 1126:185-91.
40. Hennig B, Chung BH, Watkins BA, Alvarado A. Disruption of endothelial barrier function by lipolytic remnants of triglyceride-rich lipoproteins. Atherosclerosis 1992; 95:235-47.
41. Zilversmit DB. A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins. Circ Res 1973; 33:633-8.
42. Mrhova O, Hladovec J, Urbanova D. Metabolic changes in the arterial wall and endothelial injury in experimental methioninaemia. Cor Vasa 1988; 30:72-9, 1988.
43. Fau D, Peret J, Hadjiisky P. Effects of ingestion of high protein or excess methionine diets by rats for two years. J Nutr 1988; 118:128-33.
44. McCully KS, Wilson RB. Homocysteine theory of arteriosclerosis. Atherosclerosis 1975; 22:215-27.
45. Krishnaswamy K, Rao SB. Failure to produce atherosclerosis in Macaca radiata on high-methionine, high-fat pyridoxine-deficient diet Atherosclerosis 1977; 27:253-8.
46. Toborek M, Wasik T, Drózdz M, Klin M, Magner-Wrobel K, Kopieczna-Grzebieniak E. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure. Metabolism 1992; 41:1229-32.
47. Sobczak A, Drózdz M, Kopieczna-Grzebieniak E, Toborek M, Grabowska-Bochenek R. Elastin metabolism in different models of experimental atherosclerosis. I. Measurement of elastin degradation level by determination of desmosine concentration in urine. Rev Roum Biochim 1990; 27:111-4.
48. Toborek M, Kopieczna-Grzebieniak E, Drózdz M, Wieczorek M. Increased lipid peroxidation and antioxidant activity in methionine-induced hepatitis in rabbits. Nutrition, in press.
49. Toborek M, Chmurzynska W, Manteuffel-Cymborowska M, Sikora E, Grzelakowska-Sztabert B. Enzymes of homocysteine remethylation and transsulfuration in methionine or cholesterol induced atherosclerosis in rabbits. In: Curtis HC, Ghisla S, Blau N, eds, Chemistry and Biology of Pteridines 1989, Berlin, New York: Walter de Gruyter & Co. 1990; 876-80.
50. Kang SS, Wong PW, Malinow MR. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 1992; 12:279-98.
51. Starkebaum G, Harlan JM. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1986; 77:1370-6.
52. Nordström M, Kjellström T. Age dependency of cystathionine beta-synthase activity in human fibroblasts in homocyst(e)inemia and atherosclerotic vascular disease. Atherosclerosis 1992; 94:213-21.
53. Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, Malinow MR, Maeda N. Mice deficient in cystathionine β-synthase: Animal models for mild and severe homocyst(e)inemia. Proc Natl Acad Sci USA 1995; 92:1585-9.
54. Swift ME, Shultz TD. Relationship of vitamin B-6 and B-12 to homocysteine levels: Risk for coronary heart disease Nutr Rep Int 1986; 34:1-14.
55. Serfontein WJ, Ubbink JB, De Villiers LS, Rapley CH, Becker PJ. Plasma pyridoxal 5′-phosphate level as risk index for coronary artery disease. Atherosclerosis 1985; 55:357-61.
56. Smolin LA, Crenshaw TD, Kurtycz D, Benevenga NJ. Homocyst(e)ine accumulation in pigs fed diets deficient in vitamin B-6: Relationship to atherosclerosis. J Nutr 1983; 113:2022-33.
57. Olszewski AJ. Homocysteine content of plasma in ischemic heart disease, the reducing effect of pyridoxine, folate, cobalamin, choline, riboflavin and troxerutin. Correction of a calculation error. Atherosclerosis 1991; 88:97-8.
58. Harker LA, Ross R, Slichter SJ, Scott CR. Homocystine-induced arteriosclerosis: The role of endothelial cell injury and platelet response in its genesis. J Clin Invest 1976; 58:731-41.
59. Reddy GSR, Wilcken DEL. Experimental homocysteinemia in pigs: comparison with studies in sixteen homocystinuric patients. Metabolism 1982; 31:778-83.
60. Dudman NPB, Hicks C, Lynch JF, Wilcken DEL, Wang J. Homocysteine thiolactone disposal by human arterial endothelial cells and serum in vitro. Arterioscler Thromb 1991; 11:663-70.
61. Wall RT, Harlan JM, Harker LA, Striker GE. Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res 1980; 18:113-21.
62. Dudman NPB, Hicks C, Wang J, Wilcken DEL. Human arterial endothelial cell detachment in vitro: its promotion by homocysteine and cysteine. Atherosclerosis 1991; 91:77-83.
63. Lentz SR, Sadler JE. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest 1991; 88:1906-14.
64. Harker LA, Harlan JM, Ross R. Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons. Circ Res 1983; 53:731-9.
65. Tsai J-C, Perrella MA, Yoshizumi M, Hsieh C-M, Haber E, Schlegel R, Lee M-E. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA 1994; 91:6369-73.
66. Munday R. Toxicity of thiols and disulphides: involvement of free radical species. Free Rad Biol Med 1989; 7:659-73.
67. Grisham MB, McCord JM. Cytotoxicity of reactive oxygen metabolites. In: Taylor AE, Matalon S, Ward PA eds. Physiology of Oxygen Radicals, Bethesda: American Physiological Society, 1989; 1-18.
68. Heinecke JW, Kawamura M, Suzuki L, Chait A. Oxidation of low density lipoprotein by thiols: superoxide-dependent and -independent mechanisms J Lipid Res 1993; 34:2051-61.
69. Heinecke JW, Rosen H, Suzuki L, Chait A. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J Biol Chem 1987; 262:10098-103.
70. Parthasarathy S. Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor. Biochim Biophys Acta 1987; 917:337-40.
71. Jones BG, Rose FA, Tudball N. Lipid peroxidation and homocysteine induced toxicity. Atherosclerosis 1994; 105:165-70.
72. Mattson MP, Barger SW, Begley JG, Mark RJ. Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Meth Cell Biol 1995; 46:187-215.
73. Malinow MR, Sexton G, Averbuch M, Grossman M, Wilson D, Upson B. Homocyst(e)inemia in daily practive: levels in coronary artery disease. Coron Artery Dis 1990; 1:215-20.
74. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324:1149-455.
75. Murphy-Chutorian DR, Wexman MP, Grieco AJ, Heiniger JA, Glassman E, Gaull GE, Steven KC, Feit F, Wexman K, Fox AC. Methionine intolerance: a possible risk factor for coronary artery disease. J Am Coll Cardiol 1985; 6:725-30.
76. Ubbink JB, Vermaak WJH, Bennet JM, Becker PJ, Staden DA, Bissbort S. The prevalence of homocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease. Klin Wochenschr 1991; 69:527-34.
77. Boers GHJ, Smals AGH, Trijbels JMF, Fowler B, Bakkeren JAJM, Schoonderwaldt HC, Kleijer WJ, Kloppenborg PWC. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985; 313:709-15.
78. Brattström L, Israelsson B, Norrving B, Berqvist D, Thörne J, Hultberg B, Hamfelt A. Impair homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease: effect of pyridoxine and folic acid treatment. Atherosclerosis 1990; 81:51-60.
79. Malinow MR, Kang SS, Taylor LM, Wong PWK, Coull B, Inahara T, Mukerjee D, Sexton G, Upson B. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation 1989; 79:1180-8.
80. Van den Berg M, Stehouwer CDA, Bierdrager E, Rauwerda JA. Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease. Arterioscler Thromb Vasc Biol 1996; 16:165-71.
81. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wolcken B, Pyeritz RE, Andria G, Boers GHJ, Bromberg IL, Cerone R, Fowler B, Gröbe H, Schmidt H, Schweitzer L. The natural history of homocystinuria due to cystathionine-β-synthase deficiency. Am J Hum Genet 1985; 37:1-31.
82. Brattström L, Israelsson B, Lingärde F, Hultberg B. Higher total plasma homocysteine in vitamin B-12 deficiency than in heterozygosity for homocystinuria due to cystathionine beta-synthase deficiency. Metabolism 1988; 37:175-8.
83. Kang S-S, Zhou J, Wong PWK, Kowalisyn J, Strokosch G. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Human Genet 1988; 43:414-21.
84. Kang S-S, Wong PWK, Susmano A, Norusis M, Roggie N. Thermolabile methyltetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 1991; 48:536-45.
85. Ubbink JB, Vermaak WJH, van der Merwe A, Becker PJ. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. J Nutr 1993; 57:47-53.
86. Franken DG, Boers GHJ, Blom HJ, Trijbels FJM, Kloppenborg PWC. Treatment of mild hyperhomocysteinemia in vascular disease patients. Arterioscler Thromb 1994; 14:465-70.